IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a leading precision medicine oncology company, and Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui), a global pharmaceutical company focused on ...

Perspective Therapeutics, Inc. is a radiopharmaceutical development company that is pioneering advanced treatments for cancers throughout the body. The Company has proprietary technology that ...

The Finance Minister said this on Thursday during his delivery of the 2025 Mid-year budget review to Parliament.

Tech Expert and Author Raises New Questions About Elon Musk’s Most Disruptive Project to DateAustin, TX, July 22, 2025 (GLOBE NEWSWIRE) -- A newly released presentation by bestselling author and tech ...

The presentation focuses on a trail of public comments, behind-the-scenes meetings, and a critical upcoming date—August 13, 2025. According to Altucher, that date could signify the moment Starlink ...

Ukraine has received confirmation from partners that they will provide funding for three Patriot missile defence systems and discussions are underway to finance seven more, Ukrainian President ...

City of Richmond Finance Director Sheila White has resigned from her post, a city spokesperson confirmed to CBS 6 Thursday evening.

Explore the top 10 online finance degrees from accredited universities. Our guide breaks down tuition rates, concentrations, career paths and admissions.

UBS invites you to the presentation of its results for the second quarter of 2025 on Wednesday, 30 July 2025. The results will be presented by Sergio P. Ermotti, Group Chief Executive Officer, Todd ...

Barclays explains £2,000 cash limit as 'you'll need to contact us' A customer contacted Barclays to voice their frustration after having a bad experience ...

UBS invites you to the presentation of its results for the second quarter of 2025 on Wednesday, 30 July 2025. The results will be presented by Sergio P. Ermotti, Group Chief Executive Officer, Todd ...

The prefilled syringe presentation of GSK’s shingles vaccine is also undergoing regulatory review by the European Medicines Agency (EMA), with filing acceptance received in January 2025, marking ...